WORK Medical Technology Group LTD (WOK)
NASDAQ: WOK · Real-Time Price · USD
1.120
+0.010 (0.90%)
At close: Mar 9, 2026, 4:00 PM EDT
1.100
-0.020 (-1.79%)
After-hours: Mar 9, 2026, 5:59 PM EDT

Company Description

WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People’s Republic of China and internationally.

The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators.

It also engages in the research and development of biological and medical technology; and sale of chemical products.

The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania.

WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.

WORK Medical Technology Group LTD
WORK Medical Technology Group LTD logo
Country China
Founded 2002
IPO Date Aug 23, 2024
Industry Medical Devices
Sector Healthcare
Employees 238
CEO Shuang Wu

Contact Details

Address:
No. 2 Tonghuinan Road, Floor 23
Hangzhou
China
Phone 86 571 8261 3568
Website workmedtech.com

Stock Details

Ticker Symbol WOK
Exchange NASDAQ
Share Class Class A Shares
Fiscal Year October - September
Reporting Currency USD
IPO Price $4.00
CIK Code 0001929783
CUSIP Number G9767H117
ISIN Number KYG9767H1258
SIC Code 3841

Key Executives

Name Position
Shuang Wu Chairman and Chief Executive Officer
Ningfang Liang Chief Financial Officer
Baiming Yu Chief Operating Officer and Director

Latest SEC Filings

Date Type Title
Feb 27, 2026 6-K Report of foreign issuer
Feb 10, 2026 6-K Report of foreign issuer
Jan 30, 2026 20-F Annual and transition report of foreign private issuers
Jan 5, 2026 6-K Report of foreign issuer
Dec 30, 2025 6-K Report of foreign issuer
Dec 2, 2025 6-K/A Filing
Nov 24, 2025 6-K Report of foreign issuer
Nov 24, 2025 424B5 Filing
Nov 14, 2025 SCHEDULE 13G/A Filing
Nov 7, 2025 6-K Report of foreign issuer